Clover Health Investments Corp. (CLOV)
NASDAQHealth CareMedical - Healthcare PlansSnapshot 2026-11-05
$4.48-4.48%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Healthcare PlansSnapshot 2026-11-05
QuarterlyIQ Insights · CLOV
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 33.3% |
| Our one-year growth estimate | diamond | 36.7% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 3.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 6 industry peers · Company calendar date is not available
CLOV — CFO transition
Dated 2026-11-04
CFO — Joseph Clay Thornton: The filing discloses the permanent appointment of the Interim CFO to the permanent CFO role and the promotion of the Controller to Chief Accounting Officer, which are internal promotions rather than departures.
Why it matters: This ratio tracks medical claims against insurance revenue. It rose from Q1 to Q2, so the next results can show whether costs ease.
Watch forQ3 Insurance BER is below 87.6%, improving from the Q2 result of 87.6%.
Also watch forQ3 Insurance BER is above 87.6%, showing a further rise from Q2.
Why it matters: Clover reported profits in both first-half quarters and raised its full-year outlook. Q3 results will test that path.
Supportive ifOn November 4, Q3 results show positive GAAP net income. The company keeps its $20 million to $35 million 2026 net income range.
Worry ifQ3 GAAP net income is negative, or the company cuts its 2026 net income range below $20 million.
Why it matters: The sector has led the wider market over 20 and 60 days, but its growth phase is easing. A pullback could weaken that support.
Worry ifHealth Care's 20-day relative performance turns negative. Its sector growth trend keeps slowing.
Less concerning ifHealth Care keeps positive 20-day relative performance, or sector growth speeds up toward its prior highs.
Why it matters: Member growth drives Clover's plan revenue. The Q2 count was already near the low end of its full-year range.
Supportive ifFull-year 2026 average Medicare Advantage membership is at least 156,000. This is within or above the guided range of 156,000 to 158,000.
Worry ifFull-year average membership falls below 156,000, or guidance is cut below that level.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$242 on $10,000 · ±2.4% | How much price usually moves either way. |
| Bad day | $474 loss on $10,000 · 4.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,266 loss on $10,000 · 42.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The rating supports year-round PPO enrollment and affects plan payments. The rating used a court ruling now on appeal.
Watch forCMS keeps the PPO rating at 5 Stars for payment year 2028, with no change to its rating method after the appeal.
Also watch forThe appeal or a CMS action changes the method, and CMS lowers the PPO rating to 4.5 Stars or less.